Acerca de

Anodyne at JPM Healthcare Week 2026

Anodyne will be attending the J.P. Morgan Healthcare Conference 2026, taking place January 12–15 in San Francisco, California. The event brings together healthcare leaders, innovators, investors, and strategic partners from across the industry to discuss the future of healthcare and emerging opportunities.

At Anodyne, we're advancing HeroPatch™, a transdermal drug delivery platform designed to enable the delivery of peptides, biologics, and nucleic acid therapies through a convenient, patient-friendly patch. Our lead program, ANN-101, is a once-weekly GLP-1 patch for obesity that demonstrates the platform's potential to transform injectable therapies into room-temperature-stable transdermal products.

​

Jake Lombardo (CEO) and Konstantinos Tzortzakis (CBO) will also be attending Biotech Showcase, BIO Partnering, and other events taking place throughout JPM Week. We look forward to connecting with industry leaders, sharing our recent progress, and exploring strategic partnership opportunities

​

Connect with Us: If you’ll be attending, feel free to reach out to schedule a meeting or learn more about our work at partnering@theheropatch.com